End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.85 EUR | 0.00% | +1.19% | -58.33% |
14/05 | Biophytis unveils design for obesity study | CF |
14/05 | Biophytis SA Announces the Design of its Phase 2 OBA Clinical Study in Obesity | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+10.23% | 12TCr | |
+10.29% | 11TCr | |
-9.71% | 2.34TCr | |
-1.60% | 2.21TCr | |
-9.84% | 1.83TCr | |
-41.70% | 1.66TCr | |
-14.86% | 1.6TCr | |
+6.06% | 1.4TCr | |
+19.41% | 1.17TCr |
- Stock Market
- Equities
- ALBPS Stock
- ALBPS Stock
- News Biophytis S.A.
- Biophytis to Meet with FDA to Advance Sarconeos Development Program